WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 533039
Description: C620-0696 is a novel potent inhibitor of bromodomain PHD-finger transcription factor (BPTF).
MedKoo Cat#: 533039
Chemical Formula: C24H24N4O3
Exact Mass: 416.1848
Molecular Weight: 416.481
Elemental Analysis: C, 69.21; H, 5.81; N, 13.45; O, 11.52
Synonym: C620-0696; C-620-0696; C 620-0696; C6200696; C-6200696; C 6200696;
IUPAC/Chemical Name: 5-((3-(Dimethylamino)propyl)amino)-3-((furan-3-ylmethyl)amino)-6H-anthra[1,9-cd]isoxazol-6-one
InChi Key: GHMCVYURSRCROT-UHFFFAOYSA-N
InChi Code: InChI=1S/C24H24N4O3/c1-28(2)10-5-9-25-18-12-19(26-13-15-8-11-30-14-15)22-21-20(18)23(29)16-6-3-4-7-17(16)24(21)31-27-22/h3-4,6-8,11-12,14,25-26H,5,9-10,13H2,1-2H3
SMILES Code: O=C(C1=C2C=CC=C1)C3=C(NCCCN(C)C)C=C(NCC4=COC=C4)C5=NOC2=C53
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 416.481 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Methods of treating cancer with compound C620-0696
By Leung, Lai Han Elaine; Yao, Xiao Jun; Liu, Liang; Xu, Jia Hui; Li, Ying; Wang, Qian Qian
From Granted Innovation Pat. (Aust.) (2018), AU 2018100077 A4 20180215.
2. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer
By Xu Jiahui; Wang Qianqian; Leung Elaine Lai Han; Li Ying; Fan Xingxing; Wu Qibiao; Yao Xiaojun; Liu Liang; Leung Elaine Lai Han; Leung Elaine Lai Han. From Frontiers of medicine (2019).